Founder effect in (TTTTA)exp(TTTCA)exp and pure (TTTTA)exp in familial cortical myoclonic tremor with epilepsy type 1-SAMD12 locus
Objective: To detect the founder effect between familial cortical myoclonic tremor with epilepsy type 1 (FCMTE1) patients with (TTTTA)exp(TTTCA)exp (exp, expansion) in SAMD12 and healthy controls with…Progression of Syndrome Specific Metabolic Brain Patterns in Patients with Various Parkinsonian Syndromes
Objective: To analyse the follow-up changes in the expression of the three syndrome specific metabolic patterns in a cohort of parkinsonian patients who underwent 18F-FDG…Unravelling Voice Tremor In Movement Disorders: A Machine Learning Study
Objective: The aim of this study is to achieve a direct and objective discrimination between voice samples recoded from patients with essential tremor and dysphonia…Outcome of Movement Disorders affected by Covid-19: case series from a single Movement Disorders Unit
Objective: The aim of this study is to investigate the effects of corona virus (Covid-19) infection on patients with movement disorders. Background: Since the outbreak…Impact of extended quarantine during the COVID-19 pandemic on Parkinson’s disease (PD) patients.
Objective: To determine the impact of extended quarantine during the COVID-19 pandemic in PD patients. Background: Due to the Covid-19 pandemic, various types of social…Progressive encephalomyelitis with rigidity and myoclonus in a Mexican patient
Objective: To present a case report of a Mexican patient with a progressive encephalomyelitis with rigidity and myoclonus (PERM) with a good response to steroids.…Telephone Visit Efficacy for Parkinson’s Disease During the COVID-19 Pandemic
Objective: To compare telephone and in-person visits in the clinical care of Parkinson’s disease (PD) patients. Background: There has been growing interest in using telemedicine…Home Health Management of Parkinson’s Disease Deep Brain Stimulation: A Randomized Clinical Trial
Objective: Evaluate the efficacy of home health DBS postoperative management in an effort to reduce travel burden and improve access. Background: The travel required to…Should Amantadine DR/ER Be Considered Prior to Device-Aided Therapies for Parkinson’s Disease?
Objective: Evaluate delayed release/extended release amantadine (AMT DR/ER) capsules for motor complications in patients meeting 5-2-1 criteria for device-aided therapies (DAT) in advanced Parkinson disease.…CVT-301 (levodopa inhalation powder): meta-analysis of safety in patients with Parkinson’s disease (PD)
Objective: Safety results from a phase 3, double-blind study of CVT-301 in patients with PD were combined with results from a 4-week, phase 2b, double-blind,…
- « Previous Page
- 1
- …
- 15
- 16
- 17
- 18
- 19
- …
- 132
- Next Page »